Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
43.92 USD | -0.64% | -1.55% | -14.24% |
May. 01 | HSBC Adjusts Price Target on Bristol-Myers Squibb to $45 From $50 | MT |
May. 01 | Editas Medicine, Bristol-Myers Squibb Extend Alpha-Beta T Cell Collaboration | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.24% | 89.62B | |
+30.21% | 699B | |
+25.07% | 571B | |
-4.58% | 364B | |
+18.48% | 326B | |
+2.94% | 286B | |
+14.68% | 236B | |
+4.71% | 198B | |
-12.43% | 194B | |
-3.09% | 154B |
- Stock Market
- Equities
- BMY Stock
- News Bristol-Myers Squibb Company
- Morgan Stanley Cuts Price Target on Bristol-Myers Squibb to $42 From $50, Keeps Underweight Rating